# Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer

> **NCT02687490** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 81 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Abraxane

## Key facts

- **NCT ID:** NCT02687490
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-24
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-15
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2021-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02687490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02687490, "Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02687490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*